Business Context and Reporting Period
This Form 8-K is a current report filed by Astro-Med, Inc. (not Astronova, Inc.) on November 22, 2015. The filing primarily addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to director compensation and a historical stock repurchase transaction:
- Director Compensation: April Ondis received a quarterly cash retainer of $1,750 (part of an annual $7,000 retainer).
- Restricted Stock Grant: 736 shares of restricted common stock with a value of $20,000 (pro-rated portion of the annual award).
- Stock Options: Non-qualified options to purchase 5,000 shares of common stock.
- Historical Repurchase: A stock repurchase agreement dated December 4, 2014, involved the repurchase of 500,000 shares at $12.50 per share for an aggregate price of $6,250,000.
Material Changes
The material change reported is the appointment of April Ondis to the Board of Directors on November 22, 2015. Ms. Ondis is the daughter of the company's late founder, Albert W. Ondis. As a co-executor of his estate, she is deemed to have acquired beneficial ownership of shares held by the Estate. No material changes to the company's financial condition or operations are reported in this document.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future outlook, or discussion of specific risks and contingencies. The document focuses solely on the disclosure of the director appointment and associated compensation arrangements under the Non-Employee Director Annual Compensation Program and the 2015 Equity Incentive Plan.
Investor Verification Checklist
- Verify the correct registrant name is Astro-Med, Inc., not Astronova, Inc.
- Confirm the vesting schedule for the 736 restricted shares (earlier of 12 months or next annual meeting) and the 5,000 stock options (immediately prior to next annual meeting).
- Review the attached Press Release (Exhibit 99.1) for additional context on the board appointment.
- Note that this filing does not provide updated financial results; refer to the most recent 10-K or 10-Q for financial performance data.